(Q37855823)

24 August 2017

title

Novel heterodimer antibiotics: a review of recent patent literature (English)

1 reference

24 August 2017

0 references

Daniel D Long

1

1 reference

24 August 2017

Daniel G Marquess

series ordinal

2

1 reference

24 August 2017

publication date

1 September 2009

1 reference

Future Medicinal Chemistry

24 August 2017

published in

1 reference

24 August 2017

volume

1

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

1037-1050

1 reference

Antibiotic-resistant bugs in the 21st century--a clinical super-challenge

24 August 2017

cites work

1 reference

United States resistance surveillance results for linezolid (LEADER Program for 2007).

21 January 2018

1 reference

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

Dual action-based approaches to antibacterial agents

21 January 2018

1 reference

Designed multiple ligands. An emerging drug discovery paradigm

21 January 2018

1 reference

Fragments, network biology and designing multiple ligands

21 January 2018

1 reference

Hybrid molecules with a dual mode of action: dream or reality?

21 January 2018

1 reference

Molecular hybridization: a useful tool in the design of new drug prototypes.

21 January 2018

1 reference

How many modes of action should an antibiotic have?

21 January 2018

1 reference

Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors

21 January 2018

1 reference

Recent advances in bacterial topoisomerase inhibitors

21 January 2018

1 reference

Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound

21 January 2018

1 reference

Rifamycin-mode of action, resistance, and biosynthesis

21 January 2018

1 reference

Nitroimidazole drugs--action and resistance mechanisms. II. Mechanisms of resistance

21 January 2018

1 reference

In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus

21 January 2018

1 reference

In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci

21 January 2018

1 reference

Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.

21 January 2018

1 reference

Macrolide resistance conferred by base substitutions in 23S rRNA.

21 January 2018

1 reference

Novel oxazolidinone–quinolone hybrid antimicrobials

21 January 2018

1 reference

Structure–activity relationship in the oxazolidinone–quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action

21 January 2018

1 reference

Design, Synthesis and Biological Evaluation of Oxazolidinone–Quinolone Hybrids

21 January 2018

1 reference

A multivalent approach to drug discovery for novel antibiotics

21 January 2018

1 reference

Exploring the positional attachment of glycopeptide/beta-lactam heterodimers

21 January 2018

1 reference

Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates

21 January 2018

1 reference

The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci

21 January 2018

1 reference

Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/FMC.09.87

1 reference

24 August 2017

1 reference